Bluecrux co-founder and EVP for Binocs, Geert Vanhove, has recently published an article on the company’s website outlining its vision for “handshake integration” for greater QC involvement in E2E planning. This novel approach to digitalizing the interaction between pharmaceutical Quality teams and wider Manufacturing and Supply Chain stakeholders is expected to significantly reduce e2e lead times and facilitate greater contributions by QC in overall planning processes.
Handshake integration would see a cross-platform offering from Bluecrux, including a comprehensive package that combines the company’s Consulting services with Binocs scheduling, our sister digital supply chain twin solution, Axon, and existing APS products. Together, this will provide pharmaceutical manufacturing clients with a digitally enabled, integrated planning solution that will automate many of the batch release processes that typically involve lengthy back-and-forth negotiations. Rather than all batches of the same type being assigned standard, fixed QC lead times, this approach will allow variable lead times to be calculated based on batch priority and QC availability. This dynamic approach is expected to complement the fixed Goods Receipt Processing Time that Supply Chain operatives currently rely on as the primary metric for formulating delivery expectations, allowing for a more flexible end-to-end planning process.
Additionally, it is hoped that implementing this process will facilitate greater direct communication between product release stakeholders and encourage greater QC involvement in E2E planning and S&OP decision making processes.
If you’re interested in a first look at what Binocs can offer as part of a wider Bluecrux offering, why not check out Geert’s article for a more detailed exploration of the topic? If this is something you’d like to discuss further with us, feel free to reach out today!
